Advertisement
  • Loading metrics

The Burden of Parasitic Zoonoses in Nepal: A Systematic Review

  • Brecht Devleesschauwer ,

    Brecht.Devleesschauwer@UGent.be

    Affiliations: Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium, Institute of Health and Society (IRSS), Faculty of Public Health, Université catholique de Louvain, Brussels, Belgium

  • Anita Ale,

    Affiliation: National Zoonoses and Food Hygiene Research Center, Kathmandu, Nepal

  • Paul Torgerson,

    Affiliation: Section of Epidemiology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland

  • Nicolas Praet,

    Affiliation: Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  • Charline Maertens de Noordhout,

    Affiliation: Institute of Health and Society (IRSS), Faculty of Public Health, Université catholique de Louvain, Brussels, Belgium

  • Basu Dev Pandey,

    Affiliation: Everest International Clinic and Research Center, Kathmandu, Nepal

  • Sher Bahadur Pun,

    Affiliation: Clinical Research Unit, Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal

  • Rob Lake,

    Affiliation: Institute of Environmental Science and Research, Christchurch, New Zealand

  • Jozef Vercruysse,

    Affiliation: Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium

  • Durga Datt Joshi ,

    Affiliation: National Zoonoses and Food Hygiene Research Center, Kathmandu, Nepal

    † Deceased.

  • Arie H. Havelaar,

    Affiliations: Centre for Zoonoses and Environmental Microbiology, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands

  • Luc Duchateau,

    Affiliation: Department of Comparative Physiology and Biometrics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium

  • Pierre Dorny,

    Affiliations: Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  • Niko Speybroeck

    Affiliation: Institute of Health and Society (IRSS), Faculty of Public Health, Université catholique de Louvain, Brussels, Belgium

The Burden of Parasitic Zoonoses in Nepal: A Systematic Review

  • Brecht Devleesschauwer, 
  • Anita Ale, 
  • Paul Torgerson, 
  • Nicolas Praet, 
  • Charline Maertens de Noordhout, 
  • Basu Dev Pandey, 
  • Sher Bahadur Pun, 
  • Rob Lake, 
  • Jozef Vercruysse, 
  • Durga Datt Joshi
PLOS
x

Abstract

Background

Parasitic zoonoses (PZs) pose a significant but often neglected threat to public health, especially in developing countries. In order to obtain a better understanding of their health impact, summary measures of population health may be calculated, such as the Disability-Adjusted Life Year (DALY). However, the data required to calculate such measures are often not readily available for these diseases, which may lead to a vicious circle of under-recognition and under-funding.

Methodology

We examined the burden of PZs in Nepal through a systematic review of online and offline data sources. PZs were classified qualitatively according to endemicity, and where possible a quantitative burden assessment was conducted in terms of the annual number of incident cases, deaths and DALYs.

Principal Findings

Between 2000 and 2012, the highest annual burden was imposed by neurocysticercosis and congenital toxoplasmosis (14,268 DALYs [95% Credibility Interval (CrI): 5450–27,694] and 9255 DALYs [95% CrI: 6135–13,292], respectively), followed by cystic echinococcosis (251 DALYs [95% CrI: 105–458]). Nepal is probably endemic for trichinellosis, toxocarosis, diphyllobothriosis, foodborne trematodosis, taeniosis, and zoonotic intestinal helminthic and protozoal infections, but insufficient data were available to quantify their health impact. Sporadic cases of alveolar echinococcosis, angiostrongylosis, capillariosis, dirofilariosis, gnathostomosis, sparganosis and cutaneous leishmaniosis may occur.

Conclusions/Significance

In settings with limited surveillance capacity, it is possible to quantify the health impact of PZs and other neglected diseases, thereby interrupting the vicious circle of neglect. In Nepal, we found that several PZs are endemic and are imposing a significant burden to public health, higher than that of malaria, and comparable to that of HIV/AIDS. However, several critical data gaps remain. Enhanced surveillance for the endemic PZs identified in this study would enable additional burden estimates, and a more complete picture of the impact of these diseases.

Author Summary

Various parasites that infect humans require animals in some stage of their life cycle. Infection with these so-called zoonotic parasites may vary from asymptomatic carriership to long-term morbidity and even death. Although data are still scarce, it is clear that parasitic zoonoses (PZs) present a significant burden for public health, particularly in poor and marginalized communities. So far, however, there has been relatively little attention to this group of diseases, causing various PZs to be labeled neglected tropical diseases. In this study, the authors reviewed a large variety of data sources to study the relevance and importance of PZs in Nepal. It was found that a large number of PZs are present in Nepal and are imposing an impact higher than that of malaria and comparable to that of HIV/AIDS. These results therefore suggest that PZs deserve greater attention and more intensive surveillance. Furthermore, this study has shown that even in settings with limited surveillance capacity, it is possible to quantify the impact of neglected diseases and, consequently, to break the vicious circle of neglect.

Introduction

Various parasites infecting humans depend on vertebrate animals to complete their life cycle. Humans most commonly become infected with these zoonotic parasites through consumption of infected hosts or through fecal-oral contamination. The results of these infections may vary from asymptomatic carriership to long-term morbidity and even death. Although data are still scarce, it is clear that these parasitic zoonoses (PZs) present a significant burden for public health, particularly in poor and marginalized communities [1], [2]. Moreover, PZs can lead to significant economic losses, both directly, through their adverse effects on human and animal health, and indirectly, through control measures required in the food production chain [3], [4].

Estimates of the impact of diseases on public health, generally referred to as burden of disease, may be valuable inputs for decision makers when setting policy priorities and monitoring intervention programs. In Nepal, it is now recognized that health sector needs should be prioritized, and that disease burden should be considered as one of the bases for this prioritization [5]. However, disease burden estimates are not readily available. While the World Health Organization and the Global Burden of Disease (GBD) initiative have generated such estimates for Nepal, these were largely based on regional extrapolations, and, more importantly, included only a limited number of PZs [6], [7]. If disease burden estimates are to be used for priority setting, an incomplete assessment of the burden of PZs may lead to a vicious circle of under-recognition, a wrong ranking of priorities and under-funding for research, prevention and control programs [8].

To address this issue, a disease burden assessment of PZs was conducted in Nepal. Ideally, the primary data sources for such studies would be official surveillance data and death registers. In Nepal, however, these data sources have limited value in terms of PZs. The official passive surveillance system of the Government of Nepal, the Health Management Information System (HMIS), has been reported to suffer from inconsistencies, incomplete reporting, and under-reporting from mainly central-level and private hospitals [9], [10]. Active surveillance systems are in place, but only target certain vaccine-preventable diseases, and not PZs. Death registration is reported to have a completeness rate of 32% [11]. We therefore opted for a more comprehensive approach, based on a systematic review of all possible secondary data sources related to PZs in Nepal from 1990 to 2012. This comprehensive review allowed us to identify endemic and possibly endemic PZs, and, subsequently, to quantify the disease burden of those PZs for which sufficient quantitative data were available.

Materials and Methods

The main objective of this study was to provide a comprehensive overview of the public health impact of PZs in Nepal. To this end, a step-wise approach was taken:

  1. Systematic review of national and international peer-reviewed and grey literature;
  2. Qualitative assessment: classification of considered PZs according to (presumed) endemicity status and data availability; and
  3. Quantitative assessment: quantification of health impact of endemic PZs in terms of the annual number of cases, deaths and Disability-Adjusted Life Years (DALYs), for the year 2006.

Considered PZs

The twenty PZs considered in this study are listed in Table 1. This selection is based on a recent review of the world-wide socioeconomic burden of PZs [1] and a review of emerging food-borne parasites [12], as many PZs may be classified as being food-borne. Seven of the considered PZs also belong to the group of neglected tropical diseases, i.e., leishmaniosis, cystic and alveolar echinococcosis, cysticercosis, food-borne trematodosis, schistosomosis and soil-transmitted helminthosis [13], [14].

thumbnail
Table 1. Parasitic zoonoses considered in the Nepalese burden of disease study (in alphabetical order).

http://dx.doi.org/10.1371/journal.pntd.0002634.t001

Systematic review

Direct and indirect evidence on the occurrence of the considered PZs was located through a systematic search of national and international peer-reviewed and grey literature. Direct evidence was defined as any data on prevalence, incidence or mortality of the PZ in humans. Indirect evidence was defined as occurrence of the concerned parasite in animal hosts or in the environment (e.g., water, soil). If no direct or indirect evidence could be identified from Nepal (further referred to as “local” evidence), recent case reports were sought from (North) India, Nepal's largest neighbor with whom it shares an open border in the west, south and east, and from the Tibet Autonomous Region, which borders Nepal in the north (Figure 1).

thumbnail
Figure 1. Nepal, in red, bordered by India in the south, and China in the north.

http://dx.doi.org/10.1371/journal.pntd.0002634.g001

For each PZ, we constructed a search phrase consisting of the key word “Nepal” and any element of a list containing the name of the PZ, possible synonyms, and the name(s) of the causative parasite(s) (Table S1-1 in Supporting Information S1). Manuscript titles were retrieved through searching PubMed, Web of Science, WHO Global Health Library, Asia Journals OnLine (AsiaJOL) and MedInd. If available, the major Nepalese journals were additionally searched through their websites (Table S1-2 in Supporting Information S1). In addition, the thesis libraries of Tribhuvan University (Kathmandu, Nepal) and the Institute of Animal Agriculture Sciences (Rampur, Chitwan district) were manually explored to find relevant manuscripts. Dissertations were also collected from the website of the Veterinary Public Health master course jointly organized by Chiang Mai University (Thailand) and Freie Universität Berlin (Germany), as this program has a regular intake of Nepalese students. No dissertations were sought from countries neighboring Nepal, as we did not have prior knowledge of masters courses organized in these countries with a regular intake of Nepalese students.

In a second step, the retrieved titles were screened for eligibility by applying a set of predefined criteria to the titles and, if possible, to the abstracts and full texts. Only papers published in 1990 or later were considered eligible, and no restrictions were placed on the language of publication. For the qualitative assessment, documents were only excluded if they did not relate to the PZ in question, or if they did not pertain to Nepal or Nepalese patients. For the quantitative assessment, additional restrictions were put on the year of publication (between 2000 and 2012), the study setting and population (Nepalese patients infected in Nepal), and the type of information (quantitative, thus excluding case reports and case series). Finally, additional titles were sought for using forward and backward reference searches (so-called “snowballing”). In the forward reference search, the titles eligible for the qualitative assessment were entered in Google Scholar (http://scholar.google.com/) to obtain a list of articles citing the former. The latter were then screened using the same criteria as used in the initial searches. In the backward reference search, the reference lists of the initially retrieved eligible documents were hand-searched and the same criteria were applied. The forward and backward searches were repeated until no more new information could be retrieved. Figure 2 presents a generic flow diagram of this applied search strategy.

Relevant data on study setting, diagnostic methods and study results were extracted from all eligible articles, and entered in spread sheet documents for further use.

Qualitative assessment

This initial assessment aimed at classifying the considered PZs according to their presumed endemicity status and data availability. To this end, we defined four categories:

  • Probably not endemic: there is no direct or indirect local evidence and no direct evidence from neighboring countries;
  • Potentially endemic: there is no direct or indirect local evidence, but there is direct evidence from neighboring countries; or, there is some direct local evidence, but of questionable nature, thus needing further confirmation;
  • Probably endemic & non-quantifiable: there is direct or indirect local evidence; the burden cannot be quantified due to insufficient quantitative data or uncertainty in zoonotic potential or health effects;
  • Probably endemic & quantifiable: there is direct or indirect local evidence; the burden can be quantified.

Additionally, information regarding the zoonotic nature of potentially zoonotic parasites was considered, with respect to alternative (dominant) anthroponotic transmission.

Quantitative assessment

Where possible, the prevalence of each PZ classified as “probably endemic & quantifiable” was modeled using a random effects meta-analysis in a Bayesian framework. In this model, it is assumed that the number of positive samples xi in each study results from a binomial distribution with sample size ni and a study-specific true prevalence θi, which is in its turn the result of an overall true prevalence π and a random study effect. The study effect is assumed to be normally distributed with mean zero and variance τ2. The prior distribution of τ2 is Gamma with scale and shape parameter equal to 1, while a Normal distribution with mean 0 and precision 0.001 was used as prior for the logit-transformed true prevalence. Markov chain Monte Carlo methods are used to fit the model. More information on the meta-analysis model is provided in Supporting Information S2.

If data allowed, the health impact of the concerning PZs was also quantified as the number of incident cases, deaths and DALYs. The DALY metric is a summary measure of public health, widely used in disease burden assessments and cost-effectiveness analyses [6], [7]. DALYs represent the overall number of healthy life years lost due to morbidity and mortality, hereby facilitating comparisons between diseases, and between countries and regions. The standard DALY formulas are:

DALY = YLD + YLL

YLD = Number of cases * Duration * Disability Weight

YLL = Number of deaths * Life expectancy at age of death

Calculation of DALYs was done using the standard formulas, and implemented in a fully stochastic framework using the DALY Calculator in R [15]. Supporting Information S3 presents the disease models and input distributions used for assessing the burden of the concerned PZs. We calculated undiscounted and unweighted DALYs, based on the Coale-Demeny model life table West, as our base case scenario. However, in order to enhance comparability of our estimates to estimates made by other authors, we performed scenario analyses by varying the time discount rate from 0% to 3%, by including age weighting, and by using the life expectancy table developed for the GBD 2010 study [7]. These different scenarios were denoted by DALY{K,r}, with K equal to 0 for unweighted DALYs and equal to 1 for age-weighted DALYs, and with r the time discount rate. For all scenarios, results were calculated at the population level (i.e., absolute number of DALYs per year) and at the individual level (i.e., relative number of DALYs per symptomatic case). Incident cases, deaths and DALYs were calculated for reference year 2006, i.e., the midpoint of the eligible publication period, 2000–2012. The total population size for 2006 was calculated as the mean of the population sizes estimated in the 2001 and 2011 censuses. The age and sex distribution of the 2006 population was derived from the 2006 Nepal Demographic and Health Survey [16]. Table 2 presents the resulting population sizes used in the calculations.

thumbnail
Table 2. 2006 age and sex specific population sizes used in the calculation of incident cases, deaths and DALYs.

http://dx.doi.org/10.1371/journal.pntd.0002634.t002

Ethics statement

The data collection activities required for this study were approved by the ethical review board of the Nepal Health Research Council (Ramshahpath, Kathmandu, Nepal) and of the Ghent University Hospital (Ghent, Belgium; registration number B670201111932).

Results

Systematic review

For all twenty considered PZs, we identified 267 unique peer-reviewed documents and 50 unique dissertations. All identified documents were published in English. Table 3 summarizes the results of the systematic review for each considered PZ.

Burden assessment

Table 4 presents the results of the qualitative classification of PZs. Out of the twenty considered PZs, only Anisakidae infection, zoonotic sleeping sickness (trypanosomosis) and zoonotic schistosomosis were classified as probably not endemic as no direct or indirect evidence was found. Seven PZs were classified as potentially endemic, i.e., alveolar echinococcosis, angiostrongylosis, capillariosis, dirofilariosis, gnathostomosis, sparganosis and cutaneous leishmaniosis. The ten remaining PZs were considered probably endemic, and the burden of three of these, neurocysticercosis, congenital (but not acquired) toxoplasmosis and cystic echinococcosis, could be fully quantified in terms of incident cases, deaths and DALYs.

Potentially endemic parasitic zoonoses.

No local evidence could be found for alveolar echinococcosis, angiostrongylosis, capillariosis, dirofilariosis, gnathostomosis, sparganosis. However, recent case reports of these diseases in India indicate that these might be, or become, endemic in Nepal as well. Furthermore, some local evidence has been reported on zoonotic leishmaniosis, but this information remains unconfirmed. If any of these potentially endemic PZs are indeed endemic to Nepal, their burden is probably limited to a few sporadic cases.

So far, no cases of alveolar echinococcosis have been reported from Nepal, although a case of alveolar echinococcosis in a monk having traveled to Nepal, India, and Singapore has been reported [17]. However, given the considerable burden of alveolar echinococcosis in Tibetan communities [18], and the presence of putative cases from India [19], [20], [21], there are likely to be some cases in Nepal as well [22].

Human angiostrongylosis, capillariosis, dirofilariosis, gnathostomosis and sparganosis result from accidental infection with parasites that mainly have rodents, canines or felines as definitive hosts. The latter hosts are common in Nepal, and Capillaria eggs have already been identified in dog, cat and monkey stool samples and environmental samples [23], [24], [25], [26], [27], [28], but it is unclear whether these were C. aerophila, or the clinically more important C. hepatica and C. philippinensis, which cause hepatic and intestinal capillariosis, respectively. Furthermore, Spirometra has been identified in stray dog stool samples from Kathmandu Valley [27], and Gewali [24] apparently found Gnathostoma eggs in water samples from Kathmandu. Human cases of these five PZs have not yet been reported from Nepal, but sporadic cases have been reported from India. Cases of eosinophilic meningitis due to Angiostrongylus cantonensis have been reported mainly from the southern Indian states [29], [30]. Only few cases of human intestinal and hepatic capillariosis have been reported from India so far [31], [32]. Ocular and subcutaneous manifestations of human dirofilariosis due to Dirofilaria immitis and Dirofilaria repens have been reported from southern states of India, but there have also been cases from the northern state of Punjab [33], [34]. Barua et al. [35] reported a case of Gnathostoma spinigerum in a patient from the northeastern Indian state of Meghalaya, while Mukherjee et al. [36] present a case of cutaneous gnathostomosis in a female from the northeastern Indian state of Manipur. Some sparganosis case reports from India have been published, including cerebral [37], hepatic [38] and visceral manifestations, the latter in a patient from Uttar Pradesh [39].

It is widely recognized that Nepal is endemic for Leishmania donovani, the causative agent of anthroponotic visceral leishmaniosis (AVL), locally known as kala-azar [40], [41], [42]. Although some studies have hinted at a possible zoonotic transmission route of L. donovani [43], [44], [45], we considered kala-azar as a purely anthroponotic parasitic disease, and excluded it from the current study. In addition to AVL, however, several reports have presented cases of cutaneous leishmaniosis [46], [47], [48], [49], [50], [51]. Although most of these cases have been imported, mostly from the Middle East, one report mentions a case of cutaneous leishmaniosis caused by Leishmania major in a woman not known to have lived outside Nepal [52], [53], [54]. The presence of Phlebotomus papatasi, a possible vector of L. major and L. infantum [43], [55], [56], [57], [58], [59], further suggests that Nepal might be (or become) endemic for zoonotic leishmaniosis [60].

Probably endemic parasitic zoonoses.

Trichinellosis has been confirmed in pigs, but never in humans in Nepal. Serological and/or coprological evidence of human infections with Toxocara, Diphyllobothrium, foodborne trematodes (FBT), and Taenia exists, but the population impact of these PZs is probably too low to quantify, although certain groups might be at high risk. Although patent infections with intestinal helminths and protozoa are still very common, the health impact of zoonotic intestinal helminths and protozoa could not be assessed, due to uncertainty of zoonotic potential and health effects. On the other hand, the health impact of cysticercosis, toxoplasmosis and cystic echinococcosis was deemed quantifiable.

Trichinella infection has been serologically confirmed in pigs from Kathmandu [61], [62], although Karn et al. [63] could not find seropositives in a sample of 344 pigs slaughtered in five districts of the Central Development Region of Nepal (including Kathmandu). Larvae have so far not yet been found on digestion. No human cases have been reported from Nepal, although Joshi et al. [61] mention the undocumented occurrence of sporadic cases of human trichinellosis reported from medical hospitals, and a trichinellosis outbreak has been documented from the north Indian state of Uttarakhand [64].

In a serological ELISA study, a high proportion of Nepalese people (∼80%) appeared positive for Toxocara infection [65]. Recently, two children with eosinophilia were serodiagnosed with toxocarosis [66]. Furthermore, Toxocara spp. have been identified from dogs from Kathmandu [27], [67], [68], cats from Nawalparasi and Chitwan [26], and water samples from Kathmandu [24], [25].

Diphyllobothrium has been found in dog stool samples from Kathmandu [67] and in the intestine of common carp fingerlings from a fish farm near Kathmandu [69]. Thapa [70] reports finding Diphyllobothrium eggs in the stools of 18/62 (29.0%) and 2/90 (2.2%) people of the Bote and Darai ethnic communities, respectively. Both are marginalized communities from Chitwan, and mainly depend on agriculture and fishing.

Some Nepali studies have reported trematode eggs in human and animal stools. Eggs of Fasciola spp. have been reported from buffaloes in a number of studies [71], [72], [73], [74], [75]. In community-based studies conducted in Kavre and Chitwan, Fasciola spp. eggs were reported in human stools [76], [77]. In a study of diarrheal samples from Kathmandu, eggs resembling those of Clonorchis sinensis or Opisthorchis spp. were found [78], [79]. However, as identification was based on visual identification only, confirmation is not certain. Three out of 84 children with eosinophilia presenting at a university hospital in Kavre were serologically positive for fasciolosis [66], while in another case series on eosinophilia in children, paragonimosis was suggested as a possible cause, given that a significant proportion of patients had the habit of eating undercooked fresh water crab meat [80]. In India, human cases of Fasciolopsis buski have been described from the Nepal bordering states of Bihar [81], [82] and Uttar Pradesh [83].

Taeniosis, due to Taenia solium, Taenia saginata or Taenia asiatica, is commonly reported in Nepal. Different studies indicate low taeniosis prevalences in the general public and in clinical samples (<2%), although some papers hint at high prevalences in certain ethnic groups (10–50%) (Table S3-1 in Supporting Information S3). Higher taeniosis prevalence in certain groups is possible, as discussed by Prasad et al. [84] and Devleesschauwer et al. [85], although estimates of up to 50% are somewhat doubtful. Molecular studies have identified T. asiatica and T. saginata as causes of taeniosis [85], [86], although it is to be expected that T. solium also causes taeniosis in Nepal, given its presence in animal intermediate hosts [87]. Apart from rare complications such as gastrointestinal obstruction or inflammation, the health impact of taeniosis is minimal. So far, there has only been one report describing such complications in a Nepalese patient [88]. As neither the national nor the international literature give a clear view of the probability of developing such complications, it was decided that the health impact could not be quantified.

A large number of studies have assessed the prevalence of intestinal helminths and protozoa in Nepal (Table S3-2 and S3-3 in Supporting Information S3). Community-based studies mainly targeted school children, while hospital-based studies were mostly set in large urban referral hospitals. Fewer studies looked at intestinal helminthic and protozoal infestations in HIV-AIDS patients. However, a meaningful quantification of the public health impact of zoonotic intestinal helminths and protozoa was deemed impossible, due to the uncertainty regarding the extent to which these infections are truly zoonotic and the uncertainty regarding the health effects of zoonotic species [1]. Indeed, the limited available data suggest that intestinal helminth infections are mainly due to anthroponotic species. In the large study on genetic influences of helminth susceptibility in the Jirel population of Jiri, Dolakha, only Ascaris lumbricoides was reported [89], [90]. Fecal cultures to identify hookworm larvae so far only revealed the anthroponotic hookworm species Ancylostoma duodenale and Necator americanus [91], [92]. The zoonotic relevance of intestinal protozoa remains less clear, even though genetic characterization of Giardia and Cryptosporidium from Nepal has been performed [93], [94], [95], [96]. The zoonotic potential of Blastocystis appears to be best studied [97], [98], [99], yet there is large uncertainty about the prevalence of human infection given the limited number of studies, as well as substantial doubt regarding its pathogenic nature [100].

Human cysticercosis in Nepalese people has been described since the early 1990s, mainly through reports of patients with neurocysticercosis (NCC) [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], ocular cysticercosis [112], [113], [114], [115], [116] and muscular and soft tissue cysticercosis [117], [118], [119], [120], [121], [122], [123], [124], [125]. Its public health impact however did not receive full attention until the 2000s. Hospital-based studies indicate NCC prevalences in seizure patients ranging from 7% to 73% (Table S3-5 in Supporting Information S3). The majority of these studies applied neuro-imaging. Two studies report the prevalence of NCC in hydrocephalus patients, indicating a prevalence of 1–2% [126], [127], while a recent study indicates NCC prevalence of ∼5% in patients with chronic headache [128]. A case series of three Nepalese intraventricular NCC patients molecularly identified the removed lesions as T. solium [129].

The majority of population-based studies on Toxoplasma gondii seroprevalence are from the 1990s [130], [131], [132], [133], [134], apart from two recent studies [135], [136]. T. gondii seroprevalence has also been studied in women with bad obstetric history [137], [138], [139], [140], patients with HIV/AIDS [139], [141], [142], [143], [144], ocular disorders [139] and hydrocephalus [126]. Apart from a recent case description [145], however, there appears to be no direct evidence on the impact of congenital toxoplasmosis, which is likely to represent the highest population burden [1]. As a result, it is only possible to obtain an indirect view of the impact of congenital toxoplasmosis in Nepal through population-based seroprevalence data.

Cystic echinococcosis has traditionally mostly been studied in livestock [27], [146], [147], [148], [149], [150], [151]. The few data in dogs indicate higher prevalence in areas where livestock is slaughtered [149], [152]. Since the 2000s, various case reports have been published on human hydatidosis [153], [154], [155], [156], [157], [158], [159], [160], [161]. Hospital register studies for CE cases have found low incidences [147], [162], [163]. So far, genotyping studies have revealed the presence of G1, the sheep strain in humans [164], dogs and livestock [149], [165], [166], G5 (cattle strain) in livestock [165] and G6 (camel strain) in humans [165].

Quantitative assessment. For intestinal infestations with Taenia spp., helminths and protozoa, we were able to estimate prevalence based on a random effects meta-analysis (Table 5). For neurocysticercosis, congenital toxoplasmosis and cystic echinococcosis we could estimate the number of incident cases, deaths and DALYs (Table 6; see Supporting Information S3 for more details on underlying data driving these estimates). Figure 3 visualizes the estimated burden at population and individual level, taking into account the uncertainty resulting from the parameter uncertainties, as suggested by Havelaar et al. [167]. Congenital toxoplasmosis has both a high population and patient burden, while neurocysticercosis is relatively less important at the patient level, but equally important at the population level. Cystic echinococcosis appears less important at both levels.

thumbnail
Figure 3. Population-level (DALYs{0,0} per year) versus individual-level burden (DALYs{0,0} per symptomatic case) in Nepal, 2006; the scatterplots represent 1000 random samples from each distribution, with the black symbol representing the centroid; both axes are on a log10 scale.

http://dx.doi.org/10.1371/journal.pntd.0002634.g003

Discussion

As disease burden estimates are of increasing importance for policy making and evaluation, the need for such estimates becomes eminent. In the late 1990s, the World Bank commissioned a comprehensive analysis of health care delivery in Nepal. Several recommendations were made for the further development of the Nepalese health sector, one of which was the establishment of priorities [168]. These recommendations were carried forward in the development of the Nepal Health Sector Programmes (NHSP), short-term strategic frameworks for the further development of the health sector. Since then, disease burden is recognized as one of the bases for setting program priorities [5]. However, when routine surveillance systems are performing poorly and baseline epidemiological studies are rare, these estimates are not readily available [169]. In this paper, we present the first comprehensive systematic review of the burden of PZs in Nepal. Information was sought from the international and national peer-reviewed scientific literature, and an important source of information was found in dissertations. The information found allowed qualitative assessment of the twenty PZs considered. However, quantitative estimates of prevalence or disease burden were possible for only a few.

Nepal is considered endemic for at least ten PZs, and might be endemic for seven others. Most of these diseases probably only have a small public health impact. However, neurocysticercosis and congenital toxoplasmosis are likely to impose an important burden to public health. Indeed, if we compare with the three “major” infectious diseases, we see that the estimated burden due to major clinical manifestations of three PZs, with in total 0.57 DALY{1,0.03} per 1000 people, is higher than that of the WHO 2004 GBD estimate for malaria (0.05 DALY{1,0.03} per 1000), comparable to that for HIV/AIDS (0.74 DALY{1,0.03} per 1000), but substantially lower than that for tuberculosis (5.45 DALY{1,0.03} per 1000) [6]. These comparisons suggest that greater attention for PZs in Nepal is warranted. Toxoplasmosis is for instance not reported in any official Nepalese data collection system, and cysticercosis and toxoplasmosis were not considered in the WHO 2004 GBD update [6]. As a result, the incidence of congenital toxoplasmosis remains a critical data gap, and considerable uncertainties remain regarding the epilepsy prevalence and proportion of neurocysticercosis-associated epilepsy. Data on the zoonotic potential of intestinal helminths and protozoa and their health effects are lacking, although these infections may represent a considerable additional health burden.

In our study, certain methodological choices were made with as a consequence certain limitations. First, instead of applying strict inclusion/exclusion criteria, we aimed at collecting as much relevant information as possible. Inherently, this leads to large heterogeneity in the collected quantitative data. As a result, our burden estimates have large uncertainty intervals, making it for instance impossible to statistically distinguish the burden of neurocysticercosis and congenital toxoplasmosis. For congenital toxoplasmosis, as no direct evidence was available, we estimated the incidence based on a single age-specific seroprevalence study. Clearly, this puts an important constraint on the representativeness of our resulting burden estimate. Direct evidence on the incidence of congenital toxoplasmosis (e.g., through serological studies on newborns), preferably obtained through a multi-center study, is therefore needed to confirm our burden estimate.

Second, uncertainty was introduced by the selection and valuation of the clinical outcomes for the three diseases. We based our disease models on published studies [170][173], but note that other authors applied alternative ones. For instance, Bhattarai et al. [174] also included severe headaches in their assessment of the burden of neurocysticercosis in Mexico, whereas this was deemed infeasible in our study. Likewise, the disability weights assigned to the different included clinical outcomes were derived from earlier studies [170][173], in order to enhance comparability with those studies. Nevertheless, other studies, including the GBD studies, are less transparent about their applied disease models and disability weights, impeding unambiguous comparisons. For instance, the GBD 2010 study estimated the number of DALY{0,0} in Nepal to be 667 [141–2073] for “echinococcosis” and 4220 [2786–6022] for cysticercosis [175]. Given a lack of knowledge on the disease models, disability weights and data behind these estimates, it is difficult to assess the reason for any differences or similarities with our estimates. Toxoplasmosis and other PZs appear to be absent from the GBD 2010 study.

Third, subjective methodological choices regarding the calculation of DALYs may lead to further uncertainty. We tried to deal with this source of uncertainty by calculating DALYs under different common sets of normative assumptions, i.e., no discounting and age weighting, 3% time discounting and no age weighting, 3% time discounting and age weighting; and by calculating DALYs based on both the Coale-Demeny model life table West and the new GBD 2010 life expectancy table. As expected, time discounting led to smaller burden estimates. The difference between both life tables was minimal.

In addition, this study focused on the population burden of PZs. Some PZs, however, might have an important individual burden, even though their population burden is negligible or small. Likewise, the burden suffered by specific sub-populations (e.g., caste or ethnic groups), might be much higher than average population burden [85].

Finally, due to a lack of time and resources, we had to place restrictions on the nature of the diseases to be studied, and on the nature of the burden estimates to be generated. Indeed, this study only focuses on the burden of parasitic zoonoses. However, as means for interventions are poor, future integrated control should be packaged by, for instance, simultaneously controlling cystic echinococcosis, brucellosis and rabies. This analysis should therefore be extended to the burden of bacterial and viral zoonoses in Nepal. By quantifying the burden in terms of incidence, mortality and DALYs, we also focused on the health impact of the concerned diseases. Some PZs might have an important economic impact, for example in terms of livestock health, or might reduce psycho-social wellbeing in a way not captured by the applied metrics. Truly evidence-informed priority setting and decision making should take in account all these aspects of disease burden, implying that our estimates should be complemented by others.

Despite these limitations, this study has identified the most important PZs for Nepal, as far as existing data allows. The quantitative estimates of disease burden for three of these diseases suggest that PZs deserve greater attention and more intensive surveillance. As population and disease transmission dynamics change over time, disease burden changes dynamically as well. Therefore, the presented results should be updated regularly, and this exercise should be extended to other groups of neglected diseases or even to a full national burden of disease study. We therefore hope that this study will stimulate further research, so that the overall human health burden in Nepal can be better characterized. In the long term, however, continued efforts to improve surveillance and database system at the local level should enable truly monitoring of disease burden over time.

Supporting Information

Checklist S1.

PRISMA checklist.

doi:10.1371/journal.pntd.0002634.s001

(DOC)

Supporting Information S1.

Search strategy.

doi:10.1371/journal.pntd.0002634.s002

(DOC)

Supporting Information S2.

Bayesian random-effects meta-analysis.

doi:10.1371/journal.pntd.0002634.s003

(DOC)

Supporting Information S3.

Quantitative burden assessment.

doi:10.1371/journal.pntd.0002634.s004

(DOCX)

Acknowledgments

We would like to dedicate this manuscript to the memory of Dr Durga Datt Joshi, who passed away on 25 November 2013. Dr Joshi was the pioneer researcher in the field of veterinary public health in Nepal. Long before the advent of DALYs, Dr Joshi realized the importance of zoonotic diseases, and significantly contributed to our current understanding of their epidemiology and impact.

Author Contributions

Conceived and designed the experiments: BD LD PD NS. Performed the experiments: BD AA BDP SBP DDJ. Analyzed the data: BD PT NP CMdN RL JV AHH LD PD NS. Contributed reagents/materials/analysis tools: BD AA PT NP CMdN BDP SBP RL JV DDJ AHH LD PD NS. Wrote the paper: BD AA PT NP CMdN BDP SBP RL JV DDJ AHH LD PD NS.

References

  1. 1. Torgerson PR, Macpherson CN (2011) The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol 182: 79–95. doi: 10.1016/j.vetpar.2011.07.017
  2. 2. Hotez PJ, Alibek K (2011) Central Asia's hidden burden of neglected tropical diseases. PLoS Negl Trop Dis 5: e1224. doi: 10.1371/journal.pntd.0001224
  3. 3. Torgerson PR (2013) One world health: Socioeconomic burden and parasitic disease control priorities. Vet Parasitol doi: 10.1016/j.vetpar.2013.04.004
  4. 4. Murrell KD (1991) Economic losses resulting from food-borne parasitic zoonoses. Southeast Asian J Trop Med Public Health 22 Suppl: 377–381.
  5. 5. Ministry of Health and Population (2010) Nepal Health Sector Programme – Implementation Plan II (NHSP-IP 2) 2010–2015. Kathmandu, Nepal. Available: http://www.unfpa.org/sowmy/resources/docs/library/R090_MOHNepal_2010_NHSP-IP-II_Final_Apr2010.pdf. Accessed 12 July 2013.
  6. 6. Mathers C, Fat DM, Boerma J (2008) The global burden of disease: 2004 update: World Health Organization.
  7. 7. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223.
  8. 8. Vanderelst D, Speybroeck N (2010) Quantifying the lack of scientific interest in neglected tropical diseases. PLoS Negl Trop Dis 4: e576. doi: 10.1371/journal.pntd.0000576
  9. 9. Trägård A, Shrestha IB (2010) System-wide effects of Global Fund investments in Nepal. Health Policy and Planning 25: i58–i62. doi: 10.1093/heapol/czq061
  10. 10. Nepal Health Sector Support Programme & Ministry of Health and Population (2011) Consensus building workshop on strengthening Health Management Information System (HMIS): Report outlining workshop findings, recommendations for Government & NHSSP support. Kathmandu, Nepal. 30 p.
  11. 11. Thapa A (2007) Current situation in mortality statistics in Nepal. Kathmandu, Nepal: Ministry of Health and Population. 135 p.
  12. 12. Dorny P, Praet N, Deckers N, Gabriel S (2009) Emerging food-borne parasites. Vet Parasitol 163: 196–206. doi: 10.1016/j.vetpar.2009.05.026
  13. 13. World Health Organization (2006) The control of neglected zoonotic diseases: A route to poverty alleviation. Available: http://www.who.int/zoonoses/Report_Sept06.pdf. Accessed 12 July 2013.
  14. 14. World Health Organization (2010) First WHO report on neglected tropical diseases: Working to overcome the global impact of neglected tropical diseases. Available: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf. Accessed 12 July 2013.
  15. 15. Devleesschauwer B, McDonald S, Haagsma J, Praet N, Havelaar A, Speybroeck N (2013) DALY: The DALY Calculator - A GUI for stochastic DALY calculation in R. R package version 1.2.0. Available: http://cran.r-project.org/package=DALY. Accessed 12 July 2013.
  16. 16. Ministry of Health and Population (MOHP) [Nepal], New ERA, Macro International Inc (2007) Nepal Demographic and Health Survey 2006. Kathmandu: Ministry of Health and Population, New ERA, and Macro International Inc. 291 p. Available: http://www.measuredhs.com/pubs/pdf/FR191/FR191.pdf. Accessed 12 July 2013.
  17. 17. Huang J, Wu YM, Liang PC, Lee PH (2004) Alveolar hydatid disease causing total occlusion of the inferior vena cava. J Formos Med Assoc 103: 633–636.
  18. 18. Craig PS, Li T, Qiu J, Zhen R, Wang Q, et al. (2008) Echinococcosis and Tibetan communities. Emerg Infect Dis 14: 1674–1675. doi: 10.3201/eid1410.071636
  19. 19. Taneja K, Gothi R, Kumar K, Jain S, Mani RK (1990) Peritoneal Echinococcus multilocularis infection: CT appearance. J Comput Assist Tomogr 14: 493–494.
  20. 20. Shaw AK, Gambhir RP, Chaudhry R, Jaiswal SS (2010) Ecchinococcus multilocularis causing alveolar hydatid disease liver: a rare occurrence in Indian subcontinent. Trop Gastroenterol 31: 119–120.
  21. 21. Tyagi DK, Balasubramaniam S, Sawant HV (2010) Primary calcified hydatid cyst of the brain. J Neurosci Rural Pract 1: 115–117. doi: 10.4103/0976-3147.71729
  22. 22. Torgerson PR, Keller K, Magnotta M, Ragland N (2010) The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 4: e722. doi: 10.1371/journal.pntd.0000722
  23. 23. Rai SK, Uga S, Ono K, Rai G, Matsumura T (2000) Contamination of soil with helminth parasite eggs in Nepal. Southeast Asian J Trop Med Public Health 31: 388–393.
  24. 24. Gewali L (2002) Bacteriological and helminthological assessment of the drinking water quality of Ward-19, KMC [MSc dissertation]. Kathmandu: Tribhuvan University. 80 p.
  25. 25. Thapa S (2002) Assessment of biological contamination and waterborne helminthic parasites in drinking water sources of Ward no 20, KMC [MSc dissertation]. Kathmandu: Tribhuvan University. 72 p.
  26. 26. Khanal BP (2004) Studies on some intestinal helminth parasites of Felis catus (Linnaeus, 1758) from Nawalparasi and Chitwan districts of Nepal [MSc dissertation]. Kathmandu: Tribhuvan University. 59 p.
  27. 27. Manandhar S, Horchner F, Morakote N, Kyule MN, Baumann MP (2006) Occurrence of hydatidosis in slaughter buffaloes (Bos bubalis) and helminths in stray dogs in Kathmandu Valley, Nepal. Berl Munch Tierarztl Wochenschr 119: 308–311.
  28. 28. Dhoubhadel M (2007) Prevalence of intestinal helminth parasites in Rhesus monkey (Macaca mulatta) of Swoyambhu and Nilbarahi area of Kathmandu Valley [MSc dissertation]. Kathmandu: Tribhuvan University. 58 p.
  29. 29. Malhotra S, Mehta DK, Arora R, Chauhan D, Ray S, et al. (2006) Ocular angiostrongyliasis in a child–first case report from India. J Trop Pediatr 52: 223–225. doi: 10.1093/tropej/fmi092
  30. 30. Panackel C, Cherian G, Vijayakumar K, Sharma RN (2006) Eosinophilic meningitis due to Angiostrongylus cantonensis. Indian J Med Microbiol 24: 220–221.
  31. 31. Vasantha PL, Girish N, Leela KS (2012) Human intestinal capillariasis: a rare case report from non-endemic area (Andhra Pradesh, India). Indian J Med Microbiol 30: 236–239. doi: 10.4103/0255-0857.96708
  32. 32. Nabi F, Palaha HK, Sekhsaria D, Chiatale A (2007) Capillaria hepatica infestation. Indian Pediatr 44: 781–782.
  33. 33. Gautam V, Rustagi IM, Singh S, Arora DR (2002) Subconjunctival infection with Dirofilaria repens. Jpn J Infect Dis 55: 47–48.
  34. 34. Chopra R, Bhatti SM, Mohan S, Taneja N (2012) Dirofilaria in the anterior chamber: a rare occurrence. Middle East Afr J Ophthalmol 19: 349–351. doi: 10.4103/0974-9233.97965
  35. 35. Barua P, Hazarika NK, Barua N, Barua CK, Choudhury B (2007) Gnathostomiasis of the anterior chamber. Indian J Med Microbiol 25: 276–278. doi: 10.4103/0255-0857.34775
  36. 36. Mukherjee A, Ahmed NH, Samantaray JC, Mirdha BR (2012) A rare case of cutaneous larva migrans due to Gnathostoma sp. Indian J Med Microbiol 30: 356–358. doi: 10.4103/0255-0857.99505
  37. 37. Rengarajan S, Nanjegowda N, Bhat D, Mahadevan A, Sampath S, et al. (2008) Cerebral sparganosis: a diagnostic challenge. Br J Neurosurg 22: 784–786. doi: 10.1080/02688690802088073
  38. 38. Khurana S, Appannanavar S, Bhatti HS, Verma S (2012) Sparganosis of liver: a rare entity and review of literature. BMJ Case Rep 2012.
  39. 39. Duggal S, Mahajan RK, Duggal N, Hans C (2011) Case of sparganosis: a diagnostic dilemma. Indian J Med Microbiol 29: 183–186. doi: 10.4103/0255-0857.81789
  40. 40. Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, et al. (2011) Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis 5: e1405. doi: 10.1371/journal.pntd.0001405
  41. 41. Pun SB, Pandey K, Shah R (2013) A series of case reports of autochthonous visceral leishmaniasis, mostly in non-endemic hilly areas of Nepal. Am J Trop Med Hyg 88: 227–229. doi: 10.4269/ajtmh.2012.12-0502
  42. 42. Uranw S, Meheus F, Baltussen R, Rijal S, Boelaert M (2013) The household costs of visceral leishmaniasis care in south-eastern Nepal. PLoS Negl Trop Dis 7: e2062. doi: 10.1371/journal.pntd.0002062
  43. 43. Burniston I, Roy L, Picado A, Das M, Rijal S, et al. (2010) Development of an enzyme-linked immunosorbent assay to identify host-feeding preferences of Phlebotomus species (Diptera: Psychodidae) in endemic foci of visceral leishmaniasis in Nepal. J Med Entomol 47: 902–906. doi: 10.1603/me09184
  44. 44. Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, et al. (2010) Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal. Parasitology 137: 1597–1603. doi: 10.1017/s0031182010000521
  45. 45. Bhattarai NR, Van der Auwera G, Rijal S, Picado A, Speybroeck N, et al. (2010) Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis 16: 231–237. doi: 10.3201/eid1602.090623
  46. 46. Karki P, Parija SC, George S, Das ML, Koirala S (1997) Visceral leishmaniasis with cutaneous ulcer or cutaneous leishmaniasis in Nepal. Southeast Asian J Trop Med Public Health 28: 836–837.
  47. 47. Parija SC, Jacob M, Karki BM, Sethi M, Karki P, et al. (1998) Cutaneous leishmaniasis in Nepal. Southeast Asian J Trop Med Public Health 29: 131–132.
  48. 48. Joshi A, Agrawal S, Garg VK, Thakur A, Agarwalla A, et al. (2000) Severe mucosal involvement in a patient with cutaneous leishmaniasis from Nepal. Int J Dermatol 39: 317–318. doi: 10.1046/j.1365-4362.2000.00930-4.x
  49. 49. Pandey BD, Babu E, Thapa S, Thapa LB (2006) First case of cutanous leishmaniasis in Nepalese patient. Nepal Medical College Journal: NMCJ 8: 213.
  50. 50. Neupane S, Sharma P, Kumar A, Paudel U, Pokhrel DB (2008) Cutaneous leishmaniasis: report of rare cases in Nepal. Nepal Med Coll J 10: 64–67.
  51. 51. Kayastha B, Shrestha P, Shrestha R, Jahan R (2009) Cutaneous leishmaniasis: a case report. Nepal Journal of Dermatology, Venereology & Leprology 8: 27–30. doi: 10.3126/njdvl.v8i1.5715
  52. 52. Kumar R, Ansari NA, Avninder S, Ramesh V, Salotra P (2008) Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg 102: 202–203. doi: 10.1016/j.trstmh.2007.10.017
  53. 53. Kalra NL, Arya SC (2008) Comment on: Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg 102: 618 author reply 618–619. doi: 10.1016/j.trstmh.2008.02.003
  54. 54. Kumar R, Ansari NA, Avninder S, Ramesh V, Salotra P (2008) Reply to comment on: Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg 102: 618–619. doi: 10.1016/j.trstmh.2008.03.005
  55. 55. Joshi A, Banjara M, Pokhrel S, Jimba M, Singhasivanon P, et al. (2006) Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities. Kathmandu Univ Med J (KUMJ) 4: 488–96.
  56. 56. Pandey K, Pant S, Kanbara H, Shuaibu MN, Mallik AK, et al. (2008) Molecular detection of Leishmania parasites from whole bodies of sandflies collected in Nepal. Parasitol Res 103: 293–297. doi: 10.1007/s00436-008-0967-7
  57. 57. Hamarsheh O, Presber W, Yaghoobi-Ershadi MR, Amro A, Al-Jawabreh A, et al. (2009) Population structure and geographical subdivision of the Leishmania major vector Phlebotomus papatasi as revealed by microsatellite variation. Med Vet Entomol 23: 69–77. doi: 10.1111/j.1365-2915.2008.00784.x
  58. 58. Gidwani K, Picado A, Rijal S, Singh SP, Roy L, et al. (2011) Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis 5: e1296. doi: 10.1371/journal.pntd.0001296
  59. 59. Bhandari G, Angdembe M, Rijal S, Boelaert M (2011) Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994–2006) control efforts. Nepal Medical College journal: NMCJ 13: 220.
  60. 60. Schwarz D, Andrews J, Gauchan B (2011) Visceral leishmaniasis in far western Nepal: another case and concerns about a new area of endemicity. Am J Trop Med Hyg 84: 508. doi: 10.4269/ajtmh.2011.11-0021
  61. 61. Joshi DD, Moller LN, Maharjan M, Kapel CM (2005) Serological evidence of trichinellosis in local pigs of Nepal. Vet Parasitol 132: 155–157. doi: 10.1016/j.vetpar.2005.05.046
  62. 62. Sapkota B, Hörchner F, Srikitjakarn L, Kyule M, Baumann M, et al. (2006) Seroprevalence of Trichinella in slaughter pigs in Kathmandu Valley, Nepal. Southeast Asian J Trop Med Public Health 37: 1078–1082.
  63. 63. Karn SK, Horchner F, Srikitjakarn L, Baumann M, Nockler K (2008) Cross-sectional study of Trichinella spp in pigs in CDR, Nepal using pepsin digestion and ELISA serology. Southeast Asian J Trop Med Public Health 39: 795–799.
  64. 64. Sethi B, Butola KS, Kumar Y, Mishra JP (2012) Multiple outbreaks of trichinellosis with high mortality rate. Trop Doct PMID 22472313. doi: 10.1258/td.2012.110335
  65. 65. Rai SK, Uga S, Ono K, Nakanishi M, Shrestha HG, et al. (1996) Seroepidemiological study of Toxocara infection in Nepal. Southeast Asian J Trop Med Public Health 27: 286–290.
  66. 66. Shrestha S, Singh SD, Shrestha N, Shrestha R (2012) Clinical and laboratory profile of children with eosinophilia at Dhulikhel Hospital. Kathmandu Univ Med J (KUMJ) 38: 58–62. doi: 10.3126/kumj.v10i2.7346
  67. 67. Ghimire K (2002) Prevalence of intestinal parasites in humans and dogs of KMC particularly in Ward no 19, KMC [MSc dissertation]. Kathmandu: Tribhuvan University. 68 p.
  68. 68. Karki S (2003) Prevalence of intestinal parasites in humans and dogs of KMC particularly in Ward no 20, KMC [MSc dissertation]. Kathmandu: Tribhuvan University. 69 p.
  69. 69. Rai P (2002) Study on the fish parasites of exotic fished (rainbow trout and carp) and their control measures in different culture systems [MSc dissertation]. Kathmandu: Tribhuvan University. 44 p.
  70. 70. Thapa RB (2000) Prevalence of intestinal helminth parasites in general and Taenia spp in detail, particularly in Bote and Darai communities of Vyash Muncipality-5, Kumaltari, Tanahun district of Nepal [MSc dissertation]. Kathmandu: Tribhuvan University. 91 p.
  71. 71. Pandey K (2001) Prevalence of fasciolosis in buffaloes in relation to Fasciola larvae infection in Lymnaea snails in Dev Bhumi Baluwa VDC of Kavre district [MSc dissertation]. Kathmandu: Tribhuvan University. 58 p.
  72. 72. Mahato SN, Harrison LJ (2005) Control of fasciolosis in stall-fed buffaloes by managing the feeding of rice straw. Trop Anim Health Prod 37: 285–291. doi: 10.1007/s11250-005-3076-y
  73. 73. Gurung B (2007) Prevalence of eggs of three trematode genera (Fasciola spp, Dicrocoelium spp and Schistosoma spp) in buffaloes of Satungal slaughter house, Kathmandu [MSc dissertation]. Kathmandu: Tribhuvan University. 52 p.
  74. 74. Mukhia G (2007) A study on the intestinal helminth parasites of buffaloes brought to Satungal (KTM) for slaughter purpose [MSc dissertation]. Kathmandu: Tribhuvan University. 76 p.
  75. 75. Shrestha A (2010) Prevalence of fascioliasis present in buffaloes of slaughter house in Kirtipur Municipality [MSc dissertation]. Kathmandu: Tribhuvan University. 85 p.
  76. 76. Yong TS, Sim S, Lee J, Ohrr H, Kim MH, et al. (2000) A small-scale survey on the status of intestinal parasite infections in rural villages in Nepal. Korean J Parasitol 38: 275–277. doi: 10.3347/kjp.2000.38.4.275
  77. 77. Hamano S, Kobayashi S, Ogaki T, Koga M, Kawasaki M, et al. (1999) A survey on helminthic infections in two rural communities in Nepal. Japanese Journal of Tropical Medicine and Hygiene 27: 511–515. doi: 10.2149/tmh1973.27.511
  78. 78. Uga S, Rai SK, Kimura K, Ganesh R, Kimura D, et al. (2004) Parasites detected from diarrheal stool samples collected in Nepal. Southeast Asian J Trop Med Public Health 35: 19–23.
  79. 79. Kimura K, Rai SK, Rai G, Insisiengmay S, Kawabata M, et al. (2005) Study on Cyclospora cayetanensis associated with diarrheal disease in Nepal and Loa PDR. Southeast Asian J Trop Med Public Health 36: 1371–1376.
  80. 80. Shrestha S, Timila D, Karki U, Shrestha A, Bhandary S (2012) Clinical profile of children with moderate-to-severe eosinophilia presenting to a tertiary hospital in Nepal. Trop Doct 42: 232–234. doi: 10.1258/td.2012.120284
  81. 81. Kumari N, Kumar M, Rai A, Acharya A (2006) Intestinal trematode infection in North Bihar. JNMA J Nepal Med Assoc 45: 204–206.
  82. 82. Rai S, Wadhwa V, Kharbanda P, Uppal B (2007) A case of poly-parasitism involving a trematode and four different nematodes in a migrant from Bihar. Indian J Med Microbiol 25: 62–63. doi: 10.4103/0255-0857.31066
  83. 83. Mahajan RK, Duggal S, Biswas NK, Duggal N, Hans C (2010) A finding of live Fasciolopsis buski in an ileostomy opening. J Infect Dev Ctries 4: 401–403.
  84. 84. Prasad KN, Chawla S, Jain D, Pandey CM, Pal L, et al. (2002) Human and porcine Taenia solium infection in rural north India. Trans R Soc Trop Med Hyg 96: 515–516. doi: 10.1016/s0035-9203(02)90423-2
  85. 85. Devleesschauwer B, Aryal A, Joshi DD, Rijal S, Sherchand JB, et al. (2012) Epidemiology of Taenia solium in Nepal: is it influenced by the social characteristics of the population and the presence of Taenia asiatica? Trop Med Int Health 17: 1019–1022. doi: 10.1111/j.1365-3156.2012.03017.x
  86. 86. Nkouawa A, Sako Y, Nakao M, Nakaya K, Ito A (2009) Loop-mediated isothermal amplification method for differentiation and rapid detection of Taenia species. J Clin Microbiol 47: 168–174. doi: 10.1128/jcm.01573-08
  87. 87. Joshi DD, Maharjan M, Johansen MV, Willingham AL, Gaihre YK, et al. (2004) Taeniasis/cysticercosis situation in Nepal. Southeast Asian J Trop Med Public Health 35: 252–258.
  88. 88. Chakrabarti I, Gangopadhyay M, Bandopadhyay A, Das N (2012) A rare case of gangrenous appendicitis by eggs of Taenia species. Journal of Parasitic Diseases 1–3 doi:10.1007/s12639-012-0182-4.
  89. 89. Criscione CD, Anderson JD, Raby K, Sudimack D, Subedi J, et al. (2007) Microsatellite markers for the human nematode parasite Ascaris lumbricoides: development and assessment of utility. J Parasitol 93: 704–708. doi: 10.1645/ge-1058r.1
  90. 90. Criscione CD, Anderson JD, Sudimack D, Subedi J, Upadhayay RP, et al. (2010) Landscape genetics reveals focal transmission of a human macroparasite. PLoS Negl Trop Dis 4: e665. doi: 10.1371/journal.pntd.0000665
  91. 91. Navitsky RC, Dreyfuss ML, Shrestha J, Khatry SK, Stoltzfus RJ, et al. (1998) Ancylostoma duodenale is responsible for hookworm infections among pregnant women in the rural plains of Nepal. J Parasitol 84: 647–651. doi: 10.2307/3284746
  92. 92. Rai S, Shrestha H, Nakanishi M, Kubo T, Ono K, et al. (1997) Hookworm infection recorded at an University Teaching Hospital in Kathmandu, Nepal over one decade period. Japanese Journal of Tropical Medicine and Hygiene 25: 81–84. doi: 10.2149/tmh1973.25.81
  93. 93. Singh A, Janaki L, Petri WA Jr, Houpt ER (2009) Giardia intestinalis assemblages A and B infections in Nepal. Am J Trop Med Hyg 81: 538–539.
  94. 94. Wu Z, Nagano I, Boonmars T, Nakada T, Takahashi Y (2003) Intraspecies polymorphism of Cryptosporidium parvum revealed by PCR-restriction fragment length polymorphism (RFLP) and RFLP-single-strand conformational polymorphism analyses. Appl Environ Microbiol 69: 4720–4726. doi: 10.1128/aem.69.8.4720-4726.2003
  95. 95. Wu Z, Nagano I, Boonmars T, Takahashi Y (2004) Further evidence that genotype I and genotype II of Cryptosporidium parvum are distinct. Tropical Medicine and Health 32: 5–14. doi: 10.2149/tmh.32.5
  96. 96. Feng Y, Karna SR, Dearen TK, Singh DK, Adhikari LN, et al. (2012) Common occurrence of a unique Cryptosporidium ryanae variant in zebu cattle and water buffaloes in the buffer zone of the Chitwan National Park, Nepal. Vet Parasitol 185: 309–314. doi: 10.1016/j.vetpar.2011.09.025
  97. 97. Yoshikawa H, Wu Z, Pandey K, Pandey BD, Sherchand JB, et al. (2009) Molecular characterization of Blastocystis isolates from children and rhesus monkeys in Kathmandu, Nepal. Vet Parasitol 160: 295–300. doi: 10.1016/j.vetpar.2008.11.029
  98. 98. Lee IL, Tan TC, Tan PC, Nanthiney DR, Biraj MK, et al. (2012) Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal. Parasitol Res 110: 1553–1562. doi: 10.1007/s00436-011-2665-0
  99. 99. Lee LI, Chye TT, Karmacharya BM, Govind SK (2012) Blastocystis sp.: waterborne zoonotic organism, a possibility? Parasit Vectors 5: 130. doi: 10.1186/1756-3305-5-130
  100. 100. Coyle CM, Varughese J, Weiss LM, Tanowitz HB (2012) Blastocystis: to treat or not to treat. Clin Infect Dis 54: 105–110. doi: 10.1093/cid/cir810
  101. 101. Heap BJ (1990) Cerebral cysticercosis as a common cause of epilepsy in Gurkhas in Hong Kong. J R Army Med Corps 136: 146–149. doi: 10.1136/jramc-136-03-04
  102. 102. Fegan D, Glennon J (1991) Epilepsy and disappearing lesions: adopting a wait and see policy. Bmj 302: 1402. doi: 10.1136/bmj.302.6789.1402-d
  103. 103. Prasad R, Taparia S (2004) Lateral sinus thrombosis with neurocysticercosis. Indian Pediatr 41: 1074–1075.
  104. 104. Prasad R, Singh R, Joshi B (2005) Lateral sinus thrombosis in neurocysticercosis. Trop Doct 35: 182–183. doi: 10.1258/0049475054620914
  105. 105. Sundarka M (2005) Bilateral ptosis due to neurocysticercosis in the midbrain. Nepal Journal of Neuroscience 2: 137.
  106. 106. Gurung G, Shrestha B, Shah TC (2005) Unusual presentation of neurocysticercosis: report of two cases. Nepal Journal of Neuroscience 2: 185–189.
  107. 107. Mamkin I, Sood N, Ramanan SV (2007) Taenia solium neurocysticercosis. N Engl J Med 357: 1666–1667. doi: 10.1056/nejmc070837
  108. 108. Shrestha R, Adhikari L (2009) Sequel of ring enhanced lesion on computerized tomographic scans of brain of patients presenting with seizure. Nepal Journal of Neuroscience 6: 12–14.
  109. 109. Patnaik MM, Rajasingham R, Deshpande A, Parmar G, Stauffer W (2009) The Nepalese shepherd. J Travel Med 16: 68–71. doi: 10.1111/j.1708-8305.2008.00275.x
  110. 110. Azzopardi L, Quirk J (2012) An acquired source of seizures. Bmj 344: e2991. doi: 10.1136/bmj.e2991
  111. 111. KC I, Rana K, Joshi R, Mandal A, Bhhatarai S (2011) Multiple parenchymal neurocysticercosis: a case report. Medical Journal of Shree Birendra Hospital 10: 44–45. doi: 10.3126/mjsbh.v10i1.6450
  112. 112. Rauniyar RK, Thakur SK, Panda A (2003) CT in the diagnosis of isolated cysticercal infestation of extraocular muscle. Clin Radiol 58: 154–156. doi: 10.1053/crad.2002.1101
  113. 113. Wong YC, Goh KY, Choo CT, Seah LL, Rootman J (2005) An unusual cause of acquired horizontal diplopia in a young adult. Br J Ophthalmol 89: 390–391. doi: 10.1136/bjo.2004.052258
  114. 114. Shariq SM, Adhikari BP (2007) Managing cysticercosis in anterior chamber of eye: a case report. Kathmandu Univ Med J (KUMJ) 5: 240–242.
  115. 115. Shrestha JB, Paudel P, Karmacharya PC (2008) Spontaneous extrusion of subconjunctival cysticercous cyst: a case report. Nepal Med Coll J 10: 139–140.
  116. 116. Yadav SK, Winter I, Singh SK (2009) Management of intra-vitreal cysticercosis. Nepal J Ophthalmol 1: 143–145. doi: 10.3126/nepjoph.v1i2.3692
  117. 117. Amatya BM, Kimula Y (1999) Cysticercosis in Nepal: a histopathologic study of sixty-two cases. Am J Surg Pathol 23: 1276–1279. doi: 10.1097/00000478-199910000-00014
  118. 118. Sah SP, Jha PC, Gupta AK, Raj GA (2001) An incidental case of breast cysticercosis associated with fibroadenoma. Indian J Pathol Microbiol 44: 59–61.
  119. 119. Smiti S, Sripathi H, Naik L (2003) Unusual location of Cysticercus lesions in soft tissue-report of three cases. Indian Journal of Radiology and Imaging 13: 157–158.
  120. 120. Bhandary S, Singh R, Karki P, Sinha AK (2004) Cysticercosis of tongue–diagnostic dilemma. Pac Health Dialog 11: 87–88.
  121. 121. Adhikari RC, Aryal G, Jha A, Pant AD, Sayami G (2007) Diagnosis of subcutaneous cysticercosis in fine needle aspirates: a study of 10 cases. Nepal Med Coll J 9: 234–238.
  122. 122. Agarwal A, Murty O, Jain M (2009) Fine needle aspiration cytology in the diagnosis of cysticercosis cases. Asian Pacific Journal of Tropical Medicine 2: 49–53.
  123. 123. Lakhey M, Hirachand S, Akhter J, Thapa B (2009) Cysticerci in palpable nodules diagnosed on fine needle aspiration cytology. JNMA J Nepal Med Assoc 48: 314–317.
  124. 124. Sharma P, Neupane S, Shrestha M, Dwivedi R, Paudel K (2010) An ultrasonographic evaluation of solitary muscular and soft tissue cysticercosis. Kathmandu Univ Med J (KUMJ) 8: 257–260. doi: 10.3126/kumj.v8i2.3571
  125. 125. Rai B (2012) The cysticercosis in muscles is one of the causes of lumps in human. Health Renaissance 10: 160–161. doi: 10.3126/hren.v10i2.6591
  126. 126. Mukhida K, Sharma MR, Shilpakar SK (2004) Management of hydrocephalus with ventriculoperitoneal shunts: review of 274 cases. Nepal Journal of Neuroscience 1: 104–112.
  127. 127. Karmacharya B, Kumar P (2012) A study on complications of ventriculoperitoneal shunt surgery in Bir Hospital, Kathmandu, Nepal. Nepal Journal of Medical Sciences 1: 119–122. doi: 10.3126/njms.v1i2.6612
  128. 128. Subedee A (2012) Evaluation of chronic headache by computed tomography: a retrospective study. Journal of Nobel Medical College 1: 64–71. doi: 10.3126/jonmc.v1i2.7301
  129. 129. Pant B, Devleesschauwer B, Shrestha P, Shrestha I, Praet N, et al. (2011) Intraventricular Taenia solium neurocysticercosis: a report of three cases. JNMA J Nepal Med Assoc 51: 192–195.
  130. 130. Rai SK, Shibata H, Sumi K, Kubota K, Hirai K, et al. (1994) Seroepidemiological study of toxoplasmosis in two different geographical areas in Nepal. Southeast Asian J Trop Med Public Health 25: 479–484.
  131. 131. Rai SK, Kubo T, Yano K, Shibata H, Sumi K, et al. (1996) Seroepidemiological study of Toxoplasma infection in central and western regions in Nepal. Southeast Asian J Trop Med Public Health 27: 548–553.
  132. 132. Rai SK, Shibata H, Sumi K, Rai G, Rai N, et al. (1998) Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health 29: 739–743.
  133. 133. Rai SK, Kubo T, Yano K, Shibata H, Sumi K, et al. (1998) Toxoplasma gondii infection in Eastern Nepal-a seroepidemiological study. Journal of Infectious Diseases and Antimicrobial Agents 15: 105–109.
  134. 134. Rai SK, Matsumura T, Ono K, Abe A, Hirai K, et al. (1999) High Toxoplasma seroprevalence associated with meat eating habits of locals in Nepal. Asia Pac J Public Health 11: 89–93. doi: 10.1177/101053959901100207
  135. 135. Ray R (2010) Seroprevalence of IgM and IgG antibodies against the agents of TORCH infections among the patients visiting om hospital and research center [MSc dissertation]. Kathmandu: Tribhuvan University. 64 p.
  136. 136. Imura SI, Ono K, Rai SK, Yanagida J-I, Ashitaka Y (2012) Seroprevalence of Toxoplasma gondii infection in Nepal. Bulletin of Kobe Tokiwa University 5: 9–14.
  137. 137. Rai SK, Upadhyay MP, Shrestha HG (2003) Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Med Coll J 5: 89–91.
  138. 138. Kafle P (2004) Seroprevalence of TORCH in Nepalese women of childbearing age and evaluation of biochemical parameters [MSc dissertation]. Kathmandu: Tribhuvan University. 68 p.
  139. 139. Lamichhane S, Malla S, Basnyat S, Khanal S, Dumre S, et al. (2007) Seroprevalence of IgM antibodies against the agents of TORCH infections among the patients visiting National Public Health Laboratory, Teku Kathmandu. J Nepal Health Res Counc 5: 21–25.
  140. 140. Kumari N, Morris N, Dutta R (2011) Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal. J Health Popul Nutr 29: 77–80. doi: 10.3329/jhpn.v29i1.7569
  141. 141. Graham LE, Flynn P, Patterson V (2002) Teleneuroradiology: a case from Nepal with clinical and educational benefit. J Telemed Telecare 8: 356–358.
  142. 142. Ghimire P, Sapkota D, Manandhar SP (2004) Cryptosporidiosis: opportunistic infection in HIV/AIDS patients in Nepal. J Trop Med Parasitol 27: 7–10.
  143. 143. Sapkota D, Ghimire P, Manandhar S (2004) Enteric parasitosis in patients with human immunodeficiency virus (HIV) Infection and acquired immunodeficiency syndrome (AIDS) in Nepal. J Nepal Health Res Counc 2: 9–13.
  144. 144. Lamichhane G, Shah DN, Sharma S, Chaudhary M (2010) Ocular manifestations in HIV/AIDS cases in Nepal. Nepal J Ophthalmol 2: 45–50. doi: 10.3126/nepjoph.v2i1.3704
  145. 145. Rai SK, Sharma A, Shrestha RK, Pradhan P (2011) First case of congenital toxoplasmosis from Nepal. Nepal Med Coll J 13: 64–66.
  146. 146. Maharjan M (1996) Incidence of zoonotic disease: Echinococcosis/hydatidosis in water buffaloes slaughtered for meat in Western part of Kathmandu [MSc dissertation]. Kathmandu: Tribhuvan University. 90 p.
  147. 147. Joshi DD, Joshi AB, Joshi H (1997) Epidemiology of echinococcosis in Nepal. Southeast Asian J Trop Med Public Health 28 Suppl 1: 26–31.
  148. 148. Khatri PS (2003) Study on prevalence of echinococcosis/hydatidosis in different livestock slaughtered in Banepa, Panauti and Dhulikhel municipalities of Kavre Palanchowk district and tis impact on public health [MSc dissertation]. Kathmandu: Tribhuvan University. 91 p.
  149. 149. Manandhar S (2005) Occurence of echinococcosis/hydatidosis in slaughter buffaloes and Echinococcus granulosus in stray dogs in Kathmandu Valley, Nepal [MSc dissertation]. Chiang Mai and Berlin: Chiang Mai University and Freie Universität Berlin. 76 p.
  150. 150. Sharma A (2008) Prevalence of cystic echinococcosis in buffaloes slaughtered in Kirtipur Municipality and its impact on public health [BSc dissertation]. Rampur: Tribhuvan University, Institute of Agriculture and Animal Sciences.
  151. 151. Yadav N (2009) Investigation of diagnostic indicators of echinococcosis in slaughtering buffaloes of Chitwan District, Nepal [MSc dissertation]. Rampur: Tribhuvan University, Institute of Agriculture and Animal Sciences.
  152. 152. Baronet D, Waltner-Toews D, Craig PS, Joshi DD (1994) Echinococcus granulosus infections in the dogs of Kathmandu, Nepal. Ann Trop Med Parasitol 88: 485–492.
  153. 153. Sah SP, Agrawal CS, Khan IR, Rani S (2000) Hydatid cyst presenting as a breast lump. Southeast Asian J Trop Med Public Health 31: 185–186.
  154. 154. Biswas R, Dhakal B, Das RN, Shetty KJ (2004) Resolving diagnostic uncertainty in initially poorly localizable fevers: a prospective study. Int J Clin Pract 58: 26–28. doi: 10.1111/j.1368-5031.2004.0094.x
  155. 155. Gupta D, Sharma MR, Shilpakar SK (2007) Giant hydatid cyst of brain. Nepal Journal of Neuroscience 4: 77.
  156. 156. Khan JA, Devkota P, Acharya BM, Pradhan NM, Shreshtha S (2008) Bony hydatid disease of superior pubic ramus with extension into pelvis and proximal thigh. JNMA J Nepal Med Assoc 47: 139–141.
  157. 157. Bhandari RS, Shrestha M, Shrestha GK, Mishra PR, Singh KP (2009) Abdominal lump: a diagnostic dilemma. JNMA J Nepal Med Assoc 48: 75–77.
  158. 158. Mondal SK, Sengupta SG (2009) Hydatid cyst of radial bone. JNMA J Nepal Med Assoc 48: 321–323.
  159. 159. Joshi A, Shrestha K, Shah L (2011) Infected hydatid cyst: various presentations. Postgraduate Medical Journal of NAMS 11: 59–61.
  160. 160. Subedi PP, Niyaf A, Sharma MR, Shilpakar SK (2012) Surgical management of parasitic lesions of the central nervous system: our experience. Nepal Journal of Neuroscience 9: 21–28.
  161. 161. Rauniyar R, Sharma U, Baboo S (2012) Isolated extra hepatic hydatid cyst of para spinal muscle - unusual presentation - a case report. Nepalese Journal of Radiology 2: 31–34. doi: 10.3126/njr.v2i1.6977
  162. 162. Bashyal K (2003) Case study of echinococcosis/hydatidosis in different hospitals of Kathmandu [MSc dissertation]. Kathmandu: Tribhuvan University. 60 p.
  163. 163. Gautam BP (2009) Prevalence of cystic echinococcosis/hydatidosis in slaughtered buffaloes of Kathmandu metropolitan city and assessment of its impact on public health [BSc dissertation]. Rampur: Tribhuvan University, Institute of Agriculture and Animal Sciences. 55 p.
  164. 164. Ito A, Okamoto M, Ishiguro T, Ma L, Suzuki H, et al. (1998) Short report: An imported case of cystic echinococcosis in Japan diagnosed by imaging and serology with confirmation of Echinococcus granulosus-specific DNA sequences. Am J Trop Med Hyg 58: 790–792.
  165. 165. Zhang LH, Joshi DD, McManus DP (2000) Three genotypes of Echinococcus granulosus identified in Nepal using mitochondrial DNA markers. Trans R Soc Trop Med Hyg 94: 258–260. doi: 10.1016/s0035-9203(00)90313-4
  166. 166. Joshi DD, Yamasaki H (2010) Histopathological and molecular confirmation of porcine cystic echinococcosis (CE)/hydatidosis in Nepal. Journal of Institute of Medicine 32: 54–58. doi: 10.3126/joim.v32i3.4961
  167. 167. Havelaar AH, Haagsma JA, Mangen MJ, Kemmeren JM, Verhoef LP, et al. (2012) Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol 156: 231–238. doi: 10.1016/j.ijfoodmicro.2012.03.029
  168. 168. World Bank (2000) Nepal: Operational Issues and Prioritization of Resources in the Health Sector. Kathmandu: The World Bank. 78 p. Available: http://www.healthnet.org.np/healthstat/worldbank/nepaloperational.pdf. Accessed 12 July 2013.
  169. 169. Devleesschauwer B, Ale A, Duchateau L, Dorny P, Lake R, et al. (2013) Understanding the burden of disease in Nepal: a call for local evidence. J Nepal Health Res Counc 11: 221–224.
  170. 170. Praet N, Speybroeck N, Manzanedo R, Berkvens D, Nsame Nforninwe D, et al. (2009) The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl Trop Dis 3: e406. doi: 10.1371/journal.pntd.0000406
  171. 171. Budke CM, Deplazes P, Torgerson PR (2006) Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis 12: 296–303. doi: 10.3201/eid1202.050499
  172. 172. Havelaar AH, Kemmeren JM, Kortbeek LM (2007) Disease burden of congenital toxoplasmosis. Clin Infect Dis 44: 1467–1474. doi: 10.1086/517511
  173. 173. Kortbeek LM, Hofhuis A, Nijhuis CD, Havelaar AH (2009) Congenital toxoplasmosis and DALYs in the Netherlands. Mem Inst Oswaldo Cruz 104: 370–373. doi: 10.1590/s0074-02762009000200034
  174. 174. Bhattarai R, Budke CM, Carabin H, Proaño JV, Flores-Rivera J, et al. (2012) Estimating the non-monetary burden of neurocysticercosis in Mexico. PLoS Negl Trop Dis 6: e1521. doi: 10.1371/journal.pntd.0001521
  175. 175. Institute for Health Metrics and Evaluation (2013) GBD Uncertainty Visualization [database]. Available: http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-uncertainty-visualization. Accessed 28 October 2013.